Biora Therapeutics Inc. (NASDAQ: BIOR)
$0.5461
-0.0809 ( -22.54% ) 1.9M
Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology.
Market Data
Open
$0.5461
Previous close
$0.6270
Volume
1.9M
Market cap
$2.40M
Day range
$0.5290 - $1.4050
52 week range
$0.2600 - $19.9000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 17 | Aug 12, 2024 |
10-q | Quarterly Reports | 75 | Aug 12, 2024 |
8-k | 8K-related | 47 | Jul 18, 2024 |
4 | Insider transactions | 1 | Jul 08, 2024 |
4 | Insider transactions | 1 | Jul 05, 2024 |
8-k | 8K-related | 47 | Jul 01, 2024 |
8-k | 8K-related | 16 | Jul 01, 2024 |
8-k | 8K-related | 13 | Jun 14, 2024 |
8-k | 8K-related | 14 | Jun 07, 2024 |
4 | Insider transactions | 1 | Jun 06, 2024 |